Group One Trading’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-200
Closed -$2.8K 8986
2025
Q3
$2.8K Buy
200
+100
+100% +$1.44K ﹤0.01% 7794
2025
Q2
$1.5K Sell
100
-3,200
-97% -$45.7K ﹤0.01% 7486
2025
Q1
$43.5K Buy
3,300
+500
+18% +$6.9K ﹤0.01% 5269
2024
Q4
$44.2K Buy
+2,800
New +$42.1K ﹤0.01% 5149
2015
Q3
Sell
-5,000
Closed -$55K 5128
2015
Q2
$55K Hold
5,000
﹤0.01% 3486
2015
Q1
$57K Buy
+5,000
New +$53K ﹤0.01% 3289
2014
Q4
Sell
-7,000
Closed -$74K 5207
2014
Q3
$74K Sell
7,000
-10,500
-60% -$98.7K ﹤0.01% 3251
2014
Q2
$151K Buy
17,500
+12,000
+218% +$101K ﹤0.01% 2633
2014
Q1
$48K Sell
5,500
-5,500
-50% -$47.8K ﹤0.01% 3662
2013
Q4
$90K Sell
11,000
-3,500
-24% -$27.7K ﹤0.01% 3133
2013
Q3
$110K Sell
14,500
-3,000
-17% -$21.8K ﹤0.01% 2934
2013
Q2
$132K Buy
+17,500
New +$128K ﹤0.01% 2546

Other funds holding RDY

Group One Trading's RDY Position: Q1 2026 in Review

Group One Trading sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 2,469 shares — an estimated $34.7K sold.

Group One Trading first reported a position in RDY in Q2 2013 and held it in 7 quarters. The position peaked at $380K in Q1 2016. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Group One Trading reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 2,469 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $34.7K.
  • Group One Trading first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 7 quarters.
  • Group One Trading's Dr. Reddy's Laboratories position peaked at $380K in Q1 2016.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.